Cheng K - Search Results

1

⁸⁹Zr-Labeled Multifunctional Liposomes Conjugate Chitosan for PET-Trackable Triple-Negative Breast Cancer Stem Cell Targeted Therapy.

Yang R, Lu M, Ming L, Chen Y, Cheng K, Zhou J, Jiang S, Lin Z, Chen D. Yang R, et al. Among authors: cheng k. Int J Nanomedicine. 2020 Nov 17;15:9061-9074. doi: 10.2147/IJN.S262786. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33239874 Free PMC article.

2

Determination of soluble CD44 in serum by using a label-free aptamer based electrochemical impedance biosensor.

Zhou J, Cheng K, Chen X, Yang R, Lu M, Ming L, Chen Y, Lin Z, Chen D. Zhou J, et al. Among authors: cheng k. Analyst. 2020 Jan 21;145(2):460-465. doi: 10.1039/c9an01764j. Epub 2019 Nov 29. Analyst. 2020. PMID: 31781712

3

Enhancement of tumor lethality of ROS in photodynamic therapy.

Ming L, Cheng K, Chen Y, Yang R, Chen D. Ming L, et al. Among authors: cheng k. Cancer Med. 2021 Jan;10(1):257-268. doi: 10.1002/cam4.3592. Epub 2020 Nov 3. Cancer Med. 2021. PMID: 33141513 Free PMC article. Review.

4

pH-responsive and CD44-targeting polymer micelles based on CD44p-conjugated amphiphilic block copolymer PEG-b-HES-b-PLA for delivery of emodin to breast cancer cells.

Cheng K, Zhou J, Zhao Y, Chen Y, Ming L, Huang D, Yang R, Lin Z, Chen D. Cheng K, et al. Nanotechnology. 2022 Apr 20;33(27). doi: 10.1088/1361-6528/ac5f9a. Nanotechnology. 2022. PMID: 35313287

5

Engineering RsDddA as mitochondrial base editor with wide target compatibility and enhanced activity.

Cheng K, Li C, Jin J, Qian X, Guo J, Shen L, Dai Y, Zhang X, Li Z, Guan Y, Zhou F, Tang J, Zhang J, Shen B, Lou X. Cheng K, et al. Mol Ther Nucleic Acids. 2023 Sep 9;34:102028. doi: 10.1016/j.omtn.2023.09.005. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37744175 Free PMC article.

6

Characterization of MHC/peptide complexes refolded by a one-step ion-exchange chromatography.

Shen C, He Y, Meng F, Cheng K, Zhang D, Miao F, Zhang J. Shen C, et al. Among authors: cheng k. J Immunol Methods. 2011 Jun 30;369(1-2):81-90. doi: 10.1016/j.jim.2011.04.014. Epub 2011 May 17. J Immunol Methods. 2011. PMID: 21620853

7

Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation.

Shen C, He Y, Cheng K, Zhang D, Miao S, Zhang A, Meng F, Miao F, Zhang J. Shen C, et al. Among authors: cheng k. Immunol Lett. 2011 Aug 30;138(2):144-55. doi: 10.1016/j.imlet.2011.04.002. Epub 2011 Apr 12. Immunol Lett. 2011. PMID: 21513739

8

Neoadjuvant alectinib in locally advanced lung adenocarcinoma with anaplastic lymphoma kinase rearrangement: case series and literature review.

Wang Z, Wu R, Li C, Cheng K, Di Y, Lv T, Liu H, Song Y. Wang Z, et al. Among authors: cheng k. Anticancer Drugs. 2023 Nov 1;34(10):1069-1075. doi: 10.1097/CAD.0000000000001507. Epub 2023 Jan 24. Anticancer Drugs. 2023. PMID: 36688904 Review.

9

Latex bead-based artificial antigen-presenting cells induce tumor-specific CTL responses in the native T-cell repertoires and inhibit tumor growth.

Shen C, Cheng K, Miao S, Wang W, He Y, Meng F, Zhang J. Shen C, et al. Among authors: cheng k. Immunol Lett. 2013 Feb;150(1-2):1-11. doi: 10.1016/j.imlet.2013.01.003. Epub 2013 Jan 14. Immunol Lett. 2013. PMID: 23328744

10

Analysis of the role of PANoptosis in intervertebral disk degeneration via integrated bioinformatics analysis and experimental validation.

Zhou D, Lv J, Mei Y, Song C, Liu T, Cheng K, Cai W, Gao S, Zhou Y, Xiong Z, Liu Z. Zhou D, et al. Among authors: cheng k. Int Immunopharmacol. 2024 Nov 17;143(Pt 3):113528. doi: 10.1016/j.intimp.2024.113528. Online ahead of print. Int Immunopharmacol. 2024. PMID: 39556889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,685 results

Search Page

Filters